Comera Life Sciences Holdings, Inc. (CMRA)

CMRA Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020
Revenue	0.63	0.32	0.44
Revenue Growth (YoY)	97.95%	-27.79%	-
Cost of Revenue	0.21	0.16	0.1
Gross Profit	0.42	0.16	0.34
Selling, General & Admin	10.65	3.94	1.2
Research & Development	1.74	1.75	1.26
Other Operating Expenses	-1.46	-0.08	0
Operating Expenses	12.39	5.69	2.47
Operating Income	-11.97	-5.54	-2.13
Interest Income	0.02	0	0
Interest Expense	0.02	0	0
Other Expense / Income	6.03	-0.08	-0
Pretax Income	-18	-5.45	-2.13
Income Tax	6.03	-0.16	0
Net Income	-24.04	-5.29	-2.13
Shares Outstanding (Basic)	10	19	19
Shares Outstanding (Diluted)	10	19	19
Shares Change	-45.24%	-	-
EPS (Basic)	-2.30	-0.28	-0.11
EPS (Diluted)	-2.30	-0.28	-0.11
Free Cash Flow	-9.8	-3.9	-1.82
Free Cash Flow Per Share	-0.94	-0.20	-0.10
Gross Margin	66.77%	49.66%	76.43%
Operating Margin	-1890.69%	-1730.79%	-480.34%
Profit Margin	-3796.89%	-1654.37%	-479.88%
Free Cash Flow Margin	-1547.99%	-1219.38%	-410.11%
EBITDA	-13.33	-5.61	-2.04
EBITDA Margin	-2105.79%	-1754.07%	-460.08%
Depreciation & Amortization	0.09	0.09	0.09
EBIT	-13.43	-5.7	-2.13
EBIT Margin	-2120.63%	-1781.00%	-480.34%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.